BLSG Performance — Leverage Shares 2X Long BLSH Daily ETF

Data updated: 2026-09-28

In the 12 months to Jul 2026 the fund took in a net $3.7M, and assets reached $1.21M.

BLSG Growth of $100

What $100 invested in Leverage Shares 2X Long BLSH Daily ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.

PeriodBLSGCategory average
Since data start (Oct 2025 – Jul 2026)$9$90

BLSG Trailing Returns

Total returns to Jul 2026, from SEC N-PORT.

PeriodTotal return
YTD−78.32%

BLSG Annual Returns

Calendar-year total returns of Leverage Shares 2X Long BLSH Daily ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jul)−78.32%
2025 (Oct–Dec)−56.92%

BLSG Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−39.1%+1.3%+21.8%+6.1%−19.3%−58.7%−18.5%—————
2025—————————−13.8%−30.6%−28.0%

BLSG Risk

Risk measures from monthly returns over Oct 2025 – Jul 2026.

  • Best month: +21.75% (Mar 2026)
  • Worst month: −58.65% (Jun 2026)

BLSG Fund Flows

Monthly money in and out of Leverage Shares 2X Long BLSH Daily ETF, from SEC Form N-PORT.

  • 12-month net flow: $3.7M
  • 12-month gross sales (incl. reinvestments): $5.1M
  • Sales ÷ redemptions: 3.74×
MonthSalesRedemptionsNet flow
Jul 2026$153K$235K−$82K
Jun 2026$1.4M$0$1.4M
May 2026$165K$0$165K
Apr 2026$0$132K−$132K
Mar 2026$655K$281K$374K
Feb 2026$257K$0$257K
Jan 2026$272K$129K$142K
Dec 2025$727K$217K$510K
Nov 2025$904K$105K$800K
Oct 2025$578K$266K$312K
Sep 2025$0$0$0
Aug 2025$0$0$0

BLSG Assets Under Management

Net assets of Leverage Shares 2X Long BLSH Daily ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2026-07-31$1.21M
2026-04-30$1.65M
2026-01-31$826.86K
2025-10-31$258.55K

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.